-

ZUORA LAWSUIT FILED: Investors Encouraged to Contact Kaskela Law LLC to Discuss Their Rights and Options with Respect to Proposed $10.00 Per Share Buyout

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that a shareholder lawsuit has been filed against Zuora, Inc. (NYSE: ZUO) (“Zuora”) in connection with the sale of the company to Silver Lake.

Click here for additional information: https://kaskelalaw.com/case/zuora/

Under the terms of the proposed buyout offer, Zuora stockholders are only expected to receive $10.00 per share in cash in exchange for their ZUO shares. Notably, at the time the proposed buyout at $10.00 per share was announced, numerous stock analysts were maintaining price targets for ZUO shares in excess of $12.00 per share. Following the closing of the proposed transaction, Zuora’s stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

Zuora shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to receive additional information about this investigation and their legal rights and options with respect to the proposed merger. Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/zuora/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:ZUO

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Select Medical Holdings Shareholder Buyout and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) on behalf of the company’s shareholders to determine whether the recently announced proposed buyout of SEM shareholders is fair and provides investors with sufficient monetary consideration for their shares.Click here for additional information: https://kaskelalaw.com/case/select-medical/On March 2, 2026, Select Medical announced that it had agreed to...

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Global Business Travel Group Inc. Shareholder Buyout and Encourages Investors to Contact the Firm – GBTG

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) on behalf of the company’s shareholders to determine whether the recently announced buyout of GBTG shareholders is fair and provides investors with sufficient monetary consideration for their shares. Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, Amex GBT announced that it had agreed to...

TRADEWEB: Kaskela Law Firm Announces Investigation of Tradeweb Markets Inc. (TW) and Encourages Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Tradeweb Markets Inc. (NASDAQ: TW) (“Tradeweb”) on behalf of the company’s investors. The investigation seeks to determine whether Tradeweb and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Tradeweb shareholders who would like to learn more about the investigation and their legal rights and options are encouraged...
Back to Newsroom